Abstract:Background: There is a need for a reliable, easy-to-use, widely available, and validated tool for timely cognitive impairment identification. We created a computerized cognitive screening tool (Santé-Cerveau digital tool (SCD-T)) including validated questionnaires and the following neuropsychological tests: 5 Word Test (5-WT) for episodic memory, Trail Making Test (TMT) for executive functions, and a number coding test (NCT) adapted from the Digit Symbol Substitution Test for global intellectual efficiency. This study aimed to evaluate the performance of SCD-T to identify cognitive deficit and to determine its usability. Methods: Three groups were constituted including 65 elderly Controls, 64 patients with neurodegenerative diseases (NDG): 50 AD and 14 non-AD, and 20 post-COVID-19 patients. The minimum MMSE score for inclusion was 20. Association between computerized SCD-T cognitive tests and their standard equivalent was assessed using Pearson's correlation coefficients. Two algorithms (a simple clinician-guided algorithm involving the 5-WT and the NCT; and a machine learning classifier based on 8 scores from the SCD-T tests extracted from a multiple logistic regression model, and data from the SCD-T questionnaires) were evaluated. The acceptability of SCD-T was investigated through a questionnaire and scale. Results: AD and non-AD participants were older (mean ± standard deviation (SD): 72.61 ± 6.79 vs 69.91 ± 4.86 years old, p = 0.011) and had a lower MMSE score (Mean difference estimate ± standard error: 1.74 ± 0.14, p < 0.001) than Controls; post-COVID-19 patients were younger than Controls (mean ± SD: 45.07 ± 11.36 years old, p < 0.001). All the computerized SCD-T cognitive tests were significantly associated with their reference version. In the pooled Controls and NDG group, the correlation coefficient was 0.84 for verbal memory, -0.60 for executive functions, and 0.72 for global intellectual efficiency. The clinician-guided algorithm demonstrated 94.4% ± 3.8% sensitivity and 80.5% ± 8.7% specificity, and the machine learning classifier 96.8% ± 3.9% sensitivity and 90.7% ± 5.8% specificity. The acceptability of SCD-T was good to excellent. Conclusions: We demonstrate the high accuracy of SCD-T in screening cognitive disorders and its good acceptance even in individuals with prodromal and mild dementia stages. SCD-T would be useful in primary care to faster refer subjects with significant cognitive impairment (and limit unnecessary referrals) to specialized consultation, improve the AD care pathway and the pre-screening in clinical trials.

Étude des fonctions exécutives et des troubles neurocognitifs dans la SEP primaire progressive

Évolution des troubles cognitifs dans la SEP : des trajectoires hétérogènes ?

Facteurs prédictifs des troubles cognitifs des patients avec une épilepsie génétique généralisée nouvellement diagnostiquée

Sclérose en plaques non traitée : étude de cohorte rétrospective sur la population atteinte de SEP suivie au CHU de Poitiers

La double-tâche impacte la marche dans la sclérose en plaques au stade précoce

Syndrome frontal d’apparition tardive : neurologie ou psychiatrie ?

Facteurs de risque environnementaux de la sclérose en plaques

Évaluation de la prévalence de l’hypersomnolence chez des patients adultes atteints de sclérose en plaques. Une étude observationnelle, transversale, descriptive

Validation study of "Santé-Cerveau", a digital tool for early cognitive changes identification

L’héritage que personne n’a demandé ! Caractéristiques cliniques de la sclérose en plaques familiale

Identification de biomarqueurs longitudinaux dans les ataxies spinocérébelleuses

Les signes neurovégétatifs de la sclérose en plaques

Proposition paramédicale de recours en cas de poussée chez les patients atteints de sclérose en plaques par les compétences d’infirmiers en pratique avancée (IPA)

Conséquences diagnostiques de l’étude clinico-génétique de plus de 2000 patients avec suspicion de dégénérescence lobaire frontotemporale

Cohortes digitales, mythe ou réalité ? Analyse descriptive des utilisateurs français de MSCopilot®

French consensus procedure for neuropsychological assessment in multiple sclerosis

Evaluation des Troubles Cognitifs Chez des Patients Tunisiens Atteints de Trouble Bipolaire en Rémission : Étude Cas-Témoins: Assessment of Cognitive Impairment in Tunisian Patients With Bipolar Disorder in Remission: A Case-Control Study

Multicenter Validation of the English Version of the Dépistage Cognitif de Québec: a Cognitive Screening Tool for Atypical Dementias

Altérations du système noradrénergique dans la maladie de Parkinson : une étude combinée en IRM-TEP à la 11C-yohimbine

Analyse intrathécale comparative des chimiokines liées aux lymphocytes B au cours des maladies inflammatoires du système nerveux central

Usefulness of preschool and school versions of the Behavioral Rating Inventory of Executive Functions in the evaluation of the daily life executive function in myoclonic-atonic epilepsy